TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells

James T. Lynch(AstraZeneca (United Kingdom)), Tim C. P. Somervaille(University of Manchester)

Cell Death and Disease

April 4, 2013

10.1038/cddis.2013.107

Cited by 13

Related Papers

Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia

|Cell stem cell|2019|552

Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax

|Blood|2001|110

A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia

|Journal of Clinical Investigation|2019|51

Stromal lipid species dictate melanoma metastasis and tropism

|Cancer Cell|2025|29

Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors

|British Journal of Haematology|2003|20